Featured news
-
Join our national Lunch & Learn series
Genomics is transforming healthcare - and it’s no longer a niche subject. From diagnosis to personalised treatment, genomic knowledge is becoming essential across all clinical roles.
-
Upcoming Genomics Communities of Practice meetings
Below we give a roundup upcoming meetings for our 16 Genomic Communities of Practice, which span cancers and rare and inherited conditions. Meetings will be added to this page on a rolling basis, as and when topics are confirmed and registration links go live.
-
CanRisk training for breast cancer
CanRisk is an online tool that enables healthcare professionals to calculate an individual's future risks of developing breast and ovarian cancer using cancer family history, genetic and other risk factors. CanRisk also calculates mutation carrier probabilities in breast and ovarian cancer susceptibility genes.
-
Referrals for familial hypercholesterolaemia (FH) genomic testing
It is vital for us all to work together to ensure that the NHS genomic medicine service provides the most efficient and effective support for patients.
-
NHS Genomic Medicine Service Procurement Update
The NHS Genomic Medicine Service (GMS) was launched by the Commissioner in 2018 and enables patients in the NHS in England to equitably access cutting edge genomic testing and clinical services that support diagnosis and treatment pathways for cancer, for rare and inherited disease and, in the application of pharmacogenomics, for medicines optimisation.
-
UK Government announce new 10 Year Plan for the NHS
On 3 July 2025, the Government published its 10 Year Health Plan for England, setting out ambitions for the NHS over the next 10 years.
All news
Showing 6 results
World-first trial to provide hearing for children with rare type of genetic hearing loss launches in Cambridge
Addenbrooke’s Hospital in Cambridge is participating in a world-first trial to see whether gene therapy can provide hearing for children with severe to profound hearing loss due to a rare genetic condition.
East Midlands study could pave way for new lung disease treatments
A study which academics claim is the largest and most diverse of its kind could pave the way for new potential lung disease treatments. The global study, led by universities in Leicester and Nottingham, linked more than 500 new genes to lung function for the first time.
Large number of stem cell lines carry significant DNA damage, say researchers
Cambridge researchers say detailed genetic characterisation including whole genome sequencing can help ensure safety of cell-based therapies
Largest study of whole genome sequencing data reveals new causes of cancer
Cambridge analysis of more than 12,000 tumours from NHS patients has found DNA evidence of over 50 new potential causes of cancer.
Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients, according to world first study
A world-first scientific study has shown that whole genome sequencing (WGS) can uncover new diagnoses for people across the broadest range of rare diseases investigated to date
Serena Nik-Zainal wins top prize for ground-breaking research into cancer
Professor Serena Nik-Zainal has been announced as the winner of the 2021 Foulkes Foundation Academy of Medical Sciences Medal